Renalytix PLC (LSE:RENX)
£ 0.185 -0.01 (-5.13%) Market Cap: 28.56 Mil Enterprise Value: 32.27 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 25/100

Q1 2024 Renalytix PLC Earnings Call Transcript

Nov 14, 2023 / 01:30PM GMT
Release Date Price: £0.275 (-26.67%)
Operator

Good morning, ladies and gentlemen, and welcome to the Renalytix conference call to review first quarter fiscal year 2024 financial results. At this time, all participants are in listen only mode. We will be facilitating a question and answer session towards the end of today's call.

As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Peter DeNardo of CapComm Partners for a few introductory comments.

Peter DeNardo
CapComm Partners - IR

Thank you, [Livia.] Thank you all for participating in today's call. Joining me today from Renalytix to provide formal remarks are James McCullough, CEO; Howard Doran, Chief Business Officer; Tom McLain, President; and James Sterling, CFO.

Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements made during this call that relate to expectations or predictions of future events, results, or

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot